2023-509293-29-00已完成1 期
A study in healthy people to test how well different doses of BI 3000202 are tolerated and how they affect the way the body handles midazolam
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 60
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
CT Disclosure & Data Transparency
Scientific
Boehringer Ingelheim International GmbH
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A study in healthy people to test how 2 different formulations of BI 690517 are taken up in the body and how probenecid influences the amount of BI 690517 in the blood2024-513590-45-00Boehringer Ingelheim International GmbH15
已完成
4 期
A study in healthy people to compare two different Sifrol® tablets2024-510764-23-00Boehringer Ingelheim International GmbH28
已完成
1 期
A study in healthy men to test how well different doses of BI 3802876 are tolerated2023-504538-23-00Boehringer Ingelheim International GmbH63
已完成
不适用
A study in healthy men to test how well different doses of BI 1584862 are toleratedjRCT2071230088Nippon Boehringer Ingelheim Co., Ltd.32
进行中（未招募）
不适用
A study in healthy men to test how well different doses of
BI 1819479 are toleratedjRCT2071220026Nippon Boehringer Ingelheim Co., Ltd.24